American Vanguard (AVD) Q3 2026 earnings review
American Vanguard cuts its profit plan, though customer prepayments rebound
American Vanguard, a maker of crop-protection and pest-control chemicals, saw its profit margin shrink as higher shipping costs outweighed factory savings. Third-quarter sales fell 9% to $108 million, and cash operating profit excluding one-offs dropped to breakeven from $8 million a year ago while net interest costs nearly doubled. Chief executive Dak Kaye cut the full-year sales and profit targets, though by our math the lowered plan still relies on a sharp fourth-quarter rebound.
| Net sales | $108.4M -9.2% from a year ago |
|---|---|
| Gross margin | 24.2% -4.5 percentage points from a year ago |
| Customer prepayments | $44.6M +42.9% from a year ago |
| Full-year Adjusted EBITDA outlook | Cut $8M middle of the range: $38M (-3.1% from 2025) |
⚖️ Verdict: 🔴 Bearish
The story got worse because inflation in diesel and raw materials overpowered the company's cost cuts and July price increases, forcing an $8 million reduction to the full-year cash profit plan. That drop shrinks trailing profit while high-rate term loans consume $9 million of interest per quarter. The good news: customer prepayments for the 2027 season rose 43% from a year ago to $45 million, reversing three quarters of declines and trimming net debt.
The question now is whether the third-quarter margin drop is a brief delay before price increases catch up with freight costs, or structural pressure on an older product portfolio that keeps annual cash profit stuck near $38 million while debt rules tighten. Fourth-quarter gross margin and the year-end prepayment balance will tell.
🐂 Bull Case
Customer Prepayments Rebounded 43% for Next Season
Customer prepayments — cash that buyers pay ahead of delivery for the next planting season — had trailed year-ago levels by 37% to 89% for three straight quarters. That drop forced the pesticide maker to fund its seasonal inventory with debt instead of customer cash.
In the third quarter, buyers returned to early payment programs. Prepayments rose to $44.6 million from $0.7 million in June, adding $43.9 million of cash against a $24.7 million build in the same quarter last year by our math. Chief financial officer Matt Horwath said the 44% year-over-year increase shows features that "demonstrate customer confidence and bode well for revenue in the 2027 planting season".
Because buyers paid early and receivables fell, net debt — total debt minus cash — dropped by $39.9 million during the quarter to $183.8 million by our math. One quarter of strong collections eases immediate cash pressure, but the fourth quarter is when the full winter prepayment build happens.
What to watch: customer prepayments and net debt on the December 31 balance sheet. Holding the lead over last December's $33.1 million prepayment balance would confirm that customers have permanently returned to early-pay programs.
Syngenta and Sipcam Deals Add Near-Term Products
American Vanguard wants $100 million in yearly sales from new products by 2030, and hired commercial chief Hermann Castro in July to lead that push. Because developing new agricultural chemicals takes two to three years, internal launches were not set to add meaningful revenue until 2028.
At the end of the third quarter, the crop-protection group bought ready-to-sell products instead of waiting for its own labs. Chief executive Dak Kaye said the company "acquired four U.S. brands and registrations from Syngenta® and entered into a distribution agreement with Sipcam Agro", spending $5.1 million on intangible assets in the first nine months.
Buying existing brands matters because it can bring in sales during the 2027 season, bridging the gap before internal products arrive and offsetting competition from generic copies of older products like its Folex cotton defoliant.
What to watch: the revenue contribution from the Syngenta brands and Sipcam agreement in the 2027 outlook. Management has not yet stated how much of the $100 million target these two deals cover.
🐻 Bear Case
Full-Year Sales and Profit Targets Cut
"Our actions are taking hold, and the progress we are making across American Vanguard continues to build, even as market conditions remain difficult, particularly outside the U.S., where El Niño is materially impacting our business this year," chief executive Dak Kaye said. Six weeks after holding its full-year targets in late September, the agricultural chemical maker cut them.
- Third-quarter net sales: $108.4 million, down 9.2% from a year ago
- Third-quarter Adjusted EBITDA (cash operating profit excluding one-offs): -$24 thousand, down from $8.2 million a year ago
- Full-year sales outlook: cut to $500–530 million from $530–550 million
- Full-year Adjusted EBITDA outlook: cut to $36–40 million from $44–48 million
The cut repeats 2025, when the company lowered its outlook twice and still finished below the range. By our math, the new targets imply 7.4% Adjusted EBITDA margin for 2026 — down from 7.6% in 2025 — leaving the business further from its 2028 goal of double-digit margins and $600 million in yearly sales.
What to watch: fourth-quarter net sales against the $166.3 million needed to reach the middle of the new full-year range by our math. Missing the lowered range for a second consecutive year would show that demand remains weaker than management's models assume.
Freight and Raw Materials Erased Factory Savings
American Vanguard is reorganizing its Los Angeles factory and moved its headquarters to Irvine to save at least $4.5 million a year, while raising prices in July to recover first-half shipping costs. Those self-help steps were supposed to lift second-half profit margins.
Instead, gross margin — the share of sales left after the cost of making and shipping products — fell 4.5 percentage points from a year ago to 24.2%, its lowest level in seven quarters. Cost of sales rose from 71.3% of revenue to 75.8% by our math. Kaye said factory and office savings were "more than offset by a sharp rise in diesel and other transportation costs arising from instability in the Middle East".
Lower factory volume overseas and higher raw material costs also hurt margins, Horwath added. Excluding one-off items like last year's $7.0 million product liability charge, the third-quarter operating loss widened by $6.7 million from a year ago by our math.
What to watch: fourth-quarter gross margin and the year-end confirmation that the Los Angeles plant reorganization is complete. A rebound toward 29% would show that new commercial pricing has caught up with diesel and raw material costs.
Interest Costs Consumed Half of Cash Profit
Earlier this year, the company replaced its bank credit line with term loans that carry an interest rate above 12% and charge an extra 1% payment-in-kind fee — interest added directly to the debt balance — whenever debt exceeds five times trailing cash profit.
Third-quarter net interest expense jumped 85.9% from a year ago to $9.1 million, rising by 4.3 percentage points of revenue to 8.4% by our math. Over the first nine months, net interest of $24.1 million and depreciation of $13.9 million more than consumed the $16.8 million of Adjusted EBITDA, widening the nine-month net loss to $31.7 million ($1.10 per share) from $21.7 million.
The cash flow statement shows $1.3 million of payment-in-kind leverage fees accrued in the first nine months. By our math, trailing twelve-month Adjusted EBITDA fell to $33.8 million from $42.1 million in June, pushing leverage higher ahead of stricter loan limits in December 2027.
What to watch: the first-lien leverage ratio in the third-quarter 10-Q filing against the 6.70x year-end limit. With trailing Adjusted EBITDA down by $8.3 million this quarter, cushion under the loan rules has narrowed.
International Sales Dropped 17% and Specialty Stalled
American Vanguard sells crop chemicals in the United States, non-crop pest and turf products in U.S. Specialty, and agricultural products internationally. International demand has struggled with dry El Niño weather and raw material inflation all year, while U.S. Specialty had grown 11.3% in the second quarter.
In the third quarter, every segment shrank from a year ago. International sales fell 16.9% to $47.2 million on "lower international sales and higher raw material and transportation costs", Horwath said. U.S. Specialty flipped from double-digit growth to a 1.9% decline ($18.9 million), and U.S. Crop slipped 2.3% to $42.3 million even though delayed second-quarter cotton orders were slated to ship in the period.
Three product and accounting details remain unreadable until the 10-Q filing arrives: how much reclassified foreign business-to-business revenue sat inside U.S. Crop for its final un-restated quarter, whether generic rivals took further share from Folex, and whether distributors are still buying only immediately before application.
What to watch: the Note 2 revenue table in the third-quarter 10-Q filing. It will show U.S. Crop and International sales on a like-for-like basis before the accounting reclassification laps in the fourth quarter.
👓 Other Themes
New Finance and U.S. Crop Leaders Appointed
American Vanguard hired Matt Horwath as chief financial officer and Mark Helt as president of U.S. Crop during the third quarter, following the July appointment of Hermann Castro as head of marketing and business development. The company recorded $1.3 million in one-off CFO transition costs in the period, which it excluded from Adjusted EBITDA and adjusted operating expenses.
💲 Other KPIs
Both working-capital lines shrank from a year ago as collections improved. Net trade receivables — bills customers owe for delivered products — fell 14.6% from a year ago to $142.7 million, despite a $2.5 million nine-month provision for credit losses. Inventories declined 2.5% from a year ago to $194.1 million, though rising from $181.4 million in June ahead of the fourth-quarter selling season.
Operating expenses excluding one-offs — which strip out $3.0 million of acquired product amortization, $1.7 million of transformation spending, $1.3 million of CFO transition costs, and $0.3 million of stock pay — fell 2.8% from $28.6 million a year ago. Because sales dropped 9.2%, these expenses still rose by 1.7 percentage points of revenue to 25.6% by our math.
Cash used in operations over the first nine months narrowed by $14.8 million from -$27.1 million a year ago. Because the first half used $60.5 million of operating cash, the third quarter generated $48.1 million of operating cash inflow ($45.8 million of free cash flow after $2.4 million of capital spending) by our math, driven by customer prepayments and receivable collections.
🔮 Guidance
Cut. The middle of the range dropped by $25 million to $515 million, which would leave full-year sales unchanged from 2025's $515.1 million after holding at $530–550 million for three quarters. By our math, the new plan leaves $151.3–181.3 million for the fourth quarter (+10.4% from a year ago at the middle of the range), requiring a sharp rebound after two quarters of 9% declines.
Cut. Management lowered the target by $8 million at the middle of the range to $38 million (-3.1% from 2025's $39.2 million) after holding $44–48 million since the fourth quarter of 2025. By our math, the plan leaves $19.2–23.2 million of Adjusted EBITDA for the fourth quarter (+24.5% from a year ago at the middle of the range, or a 12.7% margin on implied fourth-quarter sales).
❓ Key Questions
What drives the 25% fourth-quarter profit jump?
By our math, the lowered outlook still requires fourth-quarter Adjusted EBITDA to rise 24.5% from a year ago to $21.2 million on 10.4% sales growth. Management did not explain how gross margin will recover so quickly from 24.2%.
Where does first-lien leverage sit against the covenant?
Trailing twelve-month Adjusted EBITDA dropped from $42.1 million in June to $33.8 million in September by our math, and the 1% payment-in-kind leverage fee is accruing. The release did not disclose the exact covenant leverage ratio against the 6.70x limit.
How much revenue do Syngenta and Sipcam add in 2027?
American Vanguard spent $5.1 million on intangible assets in the first nine months and signed the Syngenta and Sipcam deals at quarter-end. Management has not stated their annual sales run-rate or gross margin.
What were like-for-like U.S. Crop and International sales?
The third quarter is the final period where year-over-year segment comparisons include foreign business-to-business sales moved from International into U.S. Crop without restatement. The release did not give the reclassified dollar amount ahead of the 10-Q filing.